Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review

No head-to-head trials have compared the efficacy and safety between the licensed dosage and administration dosage of dupilumab and benralizumab for inadequately controlled asthma. We conducted an indirect treatment comparison to estimate differences in the efficacy and safety between dupilumab and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Koichi, Tanaka, Akihiko, Sagara, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037967/
https://www.ncbi.nlm.nih.gov/pubmed/32019141
http://dx.doi.org/10.3390/ijms21030889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037967/
https://www.ncbi.nlm.nih.gov/pubmed/32019141
http://dx.doi.org/10.3390/ijms21030889

Ejemplares similares